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The effect of natural products in 
animal models of temporomandibular 
disorders
Treatment of temporomandibular disorders (TMD) is a challenge for health 
care professionals. Therefore, new approaches have been investigated, such 
as the use of natural products. Objective: This systematic review aims to 
summarize the natural products used in treatment of experimental models 
of TMD. Methodology: A systematic search was performed in the databases 
Medline, Web of Science, Scopus, Embase, SciELO, LILACS, and Scholar 
Google databases in January 2020, dating from their inception. Pre-clinical 
studies with natural products for intervention in experimental TMD were 
included. Two reviewers independently selected the studies, extracted the 
data, and evaluated the risk of bias. Results: 17 records were selected, and 
17 different natural products were found, including three lectins, three plants 
or algae extracts, three sulfated polysaccharides, three cocoa preparations, 
and five isolated compounds. Concerning the risk of bias, most studies lacked 
on randomization and blinding. Nociception induced by phlogistic agents was 
evaluated in most articles, and in five studies it was associated with analysis 
of inflammatory parameters. In order to investigate the mechanism of action 
of the natural products used, eight studies evaluated expression of neural or 
glial molecular markers. Conclusions: 16 of 17 natural products found in this 
review presented positive results, showing their potential for treatment of 
TMD. However, the lack of methodological clarity can influence these results.
Keywords: Temporomandibular joint disorders. Biological product. 
Systematic review. Preclinical drug evaluation.
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Introduction
Te m p o r o m a n d i b u l a r  d i s o r d e r s  ( T M D ) 
are multifactorial disorders that impair the 
temporomandibular joint, muscles of mastication, 
and muscle innervation of head and neck.1,2 These 
disorders approximately affect 5% of the population 
with a prevalence between 7.3% and 30.4% in the 
young people population and it can greatly affect the 
patients’ quality of life.1,3 The symptoms vary from 
mild discomfort to debilitating pain.1,3
The treatment of TMD is initially composed of 
the reduction of pain and debilitation, which can be 
achieved by several interventions with multidisciplinary 
approach. Conservative intervention includes patient 
education, physiotherapy, psychosocial management, 
occlusal splints and medicine. The association of these 
approaches is common in clinical practice.4 Generally, 
pharmacological approach, by itself or associated with 
other approaches still the main clinical approach.5 
However, the effectiveness of the available medicines 
for TMD is questionable and their side effects can limit 
their clinical use.5,6 Therefore, other alternatives have 
been investigated, such as natural products (NP). 
Natural products can include mixed substances 
present in plants and animals or even compounds 
isolated from them. Historically, they are an important 
source of active substances with therapeutic potential 
to treat several diseases, including inflammatory and 
painful conditions.7 Few clinical trials have evaluated 
natural products in patients with TMD. For example, 
a preliminary study showed that avocado/soybean 
extract decreased pain, improving the quality of 
life of patients with temporomandibular joint (TMJ) 
degeneration.8 The lack of clinical evidence on the use 
of NP to treat this condition reinforces the need for 
pre-clinical investigation. 
Some pre-clinical studies evaluated the effects 
of NP in different experimental models of TMD.9,10,11 
However, to the best of our knowledge, no study has 
systematically evaluated the use of natural products 
in experimental models of TMD. Thus, considering the 
need for new pharmacological alternatives to treat 
TMD, this study reviewed the use of different NP, 
essentially plant preparations or compounds isolated 
from plants, in pre-clinical studies involving animals 
submitted to models of TMD, to answer which NP (plant 
preparations and isolated compounds) have already 
been investigated for the treatment of experimental 
models of TMD.
Methodology
This systematic review was carried out following 
the Cochrane Collaboration Handbook and PRISMA 
Statement recommendations.12,13 
Identification and selection of studies
Eligibility Criteria
Types of study: Pre-clinical studies comparing the 
efficacy of NP and innocuous intervention (e.g., saline 
or other vehicle) for the treatment of TMD.
Types of animals (participants/conditions): 
Animals submitted to any experimental model of TMD. 
Studies that evaluated animals with associated dental 
comorbidities were excluded.
Types of intervention: Studies comparing the 
beneficial effects of NP (plant preparations and isolated 
compounds) with any innocuous treatment. There was 
no limitation regarding dosage, timing, duration of the 
treatment, frequency or administration route. Studies 
involving combined treatments were excluded.
Types of outcome measures: Primary outcomes 
were orofacial nociception measured either by 
nociceptive behavior time or by the head withdrawal 
threshold, and/or expression of mediators, 
measured by immunohistochemistry assessment. A 
secondary outcome was inflammation, measured by 
myeloperoxidase activity or histology of structures 
involved in the pathology of TMD (temporomandibular 
joint, masticatory muscles, trigeminal nerve). 
Information Sources
Studies were identified by searching the following 
electronic databases: MEDLINE via PubMed, Web 
of Science, SCOPUS, EMBASE, Scientific Electronic 
Library Online (SciELO), Latin American and Caribbean 
Literature of Information in Health Sciences (LILACS), 
and Google Scholar. Handsearching with reference lists 
of included articles was also performed. No limits for 
language or country of publication were applied. All 
electronic databases were searched from inception.
Search
Studies were identified in January 2020. Pre-
clinical studies that compared the efficacy of NPs 
with innocuous intervention were searched using 
the PICO framework. Based on the scarcity of titles 
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found in our preliminary search, the search was 
not limited to pre-clinical studies, so synonyms of 
temporomandibular disorder were used as Population/
Condition and synonyms of natural products were used 
as Intervention. The complete search strategy used 
for MEDLINE and adapted to the other databases is 
reported in Figure 1. 
Study Selection
After the identification of studies by the main 
researcher (JPO), two independent reviewers (JPO, 
MTSS) carried out the screening and eligibility analysis 
of the retrieved records. Discrepancies were resolved 
either by discussion or by a third reviewer (FKN).
Data extraction
Two independent reviewers (JPO, MTSS) extracted 
data from the included studies in a unblinded 
manner using a structured table with information 
about authors, title, year of publication, language, 
animal characteristics (species, strain, age and 
weight), number of animals per group, TMD induction 
technique, intervention characteristics (type of NP, 
dosage of NP, duration of treatment, frequency and 
route of administration, and timing relative to TMD 
induction), and control characteristics. 
Data extraction was performed following this 
sequence: (i) extract data from text or tables, (ii) 
extract data from figures (data labels) and then (iii) 
contact the correspondent author for unpublished 
data. Other authors were randomly contacted if no 
answer was obtained within a week or there was no 
contact information. If no answer was received after 
three weeks, the study was excluded from the analysis.
Risk of Bias of Individual Studies
The evaluation of bias of the included studies was 
assessed by applying the SYRCLE’s Risk of Bias tool.14 
Two independent reviewers (JPO, MTSS) assessed 
the internal validity of individual studies. The domain 
“another risk of bias,” was evaluated according to 
whether the study assessed or provided information 
about locomotor evaluation of the NP tested, the 
period in which the experiments were performed 




The electronic database search yielded 731 
records: 246 from MEDLINE; 89 from SCOPUS; 
253 from EMBASE; 11 from Web of Science; 9 from 
LILACS; 23 from SciELO, and 100 from Google Scholar. 
After excluding duplicates and including results of 
handsearching (n=1), 640 records remained. A total 
of 612 studies were excluded after title and abstract 
screening, then, 28 studies remained, of which 11 
were excluded after full-text analysis for they did not 
present the review criteria. Thus, 17 studies were 
included in the qualitative synthesis (Figure 2).
Characteristics of included studies
Out of the 17 included studies, 14 described the 
use of plant and algae preparations, including crude 
extracts (4 studies), sulfated polysaccharide (3 
studies), powder (2 studies), and lectins (5 studies); 
and three used isolated compounds. All studies were 
performed with rats and 76.47% of these evaluated 
nociception as an outcome, while inflammation was 
measured by 4 studies, and 5 studies assessed the 
expression of markers for neural or glial activation. 
Further details about the included studies are 
presented in Figure 3.
Risk of bias assessment
Figure 4 shows that all included studies presented 
low risk of bias to ‘baseline characteristics,’ but no study 
Population/Condition temporomandibular joint disorders OR disorder, temporomandibular joint OR disorders, temporomandibular 
joint OR joint disorder, temporomandibular OR joint disorders, temporomandibular OR temporomandibular 
joint disorder OR tmj disorders OR disorder, tmj OR disorders, tmj OR tmj disorder OR temporomandibular 
disorders OR disorder, temporomandibular OR disorders, temporomandibular OR temporomandibular disorder 
OR temporomandibular joint diseases OR disease, temporomandibular joint OR diseases, temporomandibular 
joint OR joint disease, temporomandibular OR joint diseases, temporomandibular OR temporomandibular joint 
disease OR tmj diseases OR disease, tmj OR diseases, tmj OR tmj disease
Intervention ethnobotan* OR Ethnopharmacolog* OR ethnobotan* OR caatinga OR innerbark OR traditional chinese 
medicine OR chinese medicine OR chinese medicine OR natural products OR natural product OR plant OR 
plants OR phytother* OR terpenes flavonoid OR coumarin OR xanthone OR chromone OR lignan OR neolignan 
OR tannin OR saponin OR alkaloid OR xanthine OR methylxanthine
Figure 1- Search strategy
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presented low risk of bias to ‘allocation concealment,’ 
‘random housing,’ ‘blinding for intervention,’ or 
‘random outcome assessment.’ Only one study 
presented low risk of bias to ‘sequence generation.’ 
At least 50% of the studies presented low risk of bias 
for ‘outcome rater blinding’ (8 studies), ‘incomplete 
outcome data’ (11 studies) or ‘selective outcome 
reporting’ (14 studies). 
Effects of interventions – Outcomes
Nociception
In total, six studies evaluated nociception by 
measuring the effect of a mechanical stimulus in the 
orofacial region. They showed that intervention with 
ethanol extract from roots of Tephrosia toxicaria,15 
lectins isolated from Caulerpa cupressoides9 or 
from Abelmoschus esculentus seeds,16 the sulfated 
polysaccharide fraction from C. cupressoides17, and the 
purple extract18 reduced nociceptive behavior induced 
by algesic stimuli in rats.
Seven studies investigated the effect of natural 
products on animals injected with formalin in the TMJ. 
The treatment with sulfated polysaccharides originated 
from the seaweed Solieria filiformis,19 with polysulfated 
fraction of the seaweed Gracilaria cornea,11 lectins 
isolated from Artocarpus incisa,10 C. cupressoides20 and 
A. esculentus,21 (−)-α-bisabolol (topical or systemic)22 
or eucalyptol reduced formalin-induced nociception in 
the TMJ.23 Four studies investigated NP in zymosan-
induced nociception. These studies showed that 
ethanol extract from roots of T. toxicaria,15 lectins 
from the green seaweed C. cupressoides9 and seeds 
of A. esculentus21, and the sulfated polysaccharide 
fraction from C. cupressoides17 reduced nociception 
induced by zymosan. One study used nerve growth 
factor (NGF) to induce nociception in masseter muscle. 
In this study, cannabidiol and cannabinol, but not 
cannabichromene, reduced the mechanical sensitivity 
caused for this model.24
Inflammation
Only five studies evaluated inflammatory 
parameters associated with the orofacial nociception. 
These studies used the zymosan model injection 
in TMJ to induce joint inflammation and associated 
nociception. 
Thus, the treatment with the ethanol extract of 
roots of T. toxicaria,15 a lectin from C. cupressoides,9 
a lectin from A. esculentus16 and the sulfated 
polysaccharide fraction of C. cupressoides17 decreased 
myeloperoxidase activity and leukocyte counts in 
synovial lavage. This effect was accompanied by 
a reduction of histological alterations induced by 
zymosan in the TMJ for the highest dose of each study, 
with the exception of one study17 in which this analysis 
was not performed.
Immunohistochemistry assessment 
In order to characterize some mechanisms 
underlying the effect of the ethanol extract from T. 
toxicaria, the study by Val, et al.15 (2014) showed 
that the treatment with this extract increased the 
expression of heme oxygenase-1 (HO-1) in the 
model of zymosan-induced TMJ inflammation and 
Figure 2- Flow chart of literature search
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Natural
product Dose and route/time of administration
Animal 
characteristics




Outcome: Nociception and/or inflammation
(−)-α-bisabolol
T: 100, 200, 400 mg/kg (per oral) or 50, 100, 
200 mg/mL (topical); C: vehicle (1% Tween 80 
in saline) / Single dose 30 minutes before the 
injection of nociceptive stimulus 
Male Wistar rats; 
weight: 200-300 
g; age: adult; n=6 
or 8 per group
Single injection of formalin 




All doses (systemic or 
topical) reduced face rubbing 






T: 1 or 5 mg/mL of cannabidiol, or 1 mg/
mL of cannabinol and cannabichromene 
(intramuscular, 10 µL, in masseter muscle); 
Control: (phosphate buffered saline, 10 μL)/ 





g; age: not 
available; n=6 per 
group
Single injection of nerve 
grown factor (25 μg/mL, 





Only cannabidiol and 
cannabinol reduced the 
mechanical sensitivity 
induced by nerve grown 








T: 0.2, 2, 20 mg/kg (per oral); C: vehicle (saline) 
/ Single dose one hour before the injection of 
zymosan
Male Wistar rats; 
weight: 160-220 
g; age: adult; n=6 
per group
Single injection of 
zymosan (2 mg; 50 µL, 6 






All doses reduced 
hyperalgesia and MPO 
activity; the dose of 20 mg/
kg reduced inflammatory 




from purple corn 
and yellow corn
T: 53 mg/kg/day on diet; C: water; During 14 
days before induction
Sprague-Dawley 
rats; age: N/A; 
weight: 200-250 
g, n=8-9 per 
group
Single injection of CFA 
(1:1 in saline, 60 µL, 24, 






In the all periods evaluated 
after the CFA injection, 
the extract reduced the 
mechanical allodynia. The 
expression of Iba-1 was 




T: 200 mg/kg (v.o.); C: vehicle (saline)/ Single 
dose 60 minutes before injection of nociceptive 
stimulus
Male Wistar rats; 
weight: 250-300 
g, age: N/A, n=6 
per group
Single injection of formalin 
(1.5%, 50 µL, 36 minutes) 
or mustard oil (2.5%, 50 




Eucalyptol reduced the 
nociceptive behavior induced 
by formalin and mustard oil
23




T: 0.5 mg/kg (intraperitoneal); C: vehicle 
(saline); Single dose 30 minutes before the 
injection of nociceptive stimulus 
Wistar rats; 
weight: 20-25 
g/250-300 g; age: 
N/A; n=6 per 
group
Single injection of formalin 















T: 0.1, 1 and 10 mg/kg (i.v.); C: vehicle (saline 
0.9%) / Single dose 30 minutes before zymosan 
injection 
Male Wistar rats; 
weight: 180-240g; 
age: adult; n=6 
per group.
Single injection of 
zymosan (2 mg; 50 µL, 6 







All doses reduced 
hyperalgesia and MPO 
activity; the dose of 
10 mg/kg reduced the 
inflammatory parameters 
in histopathological 
analysis and IL-1β, TNF-α 
expression, but did not alter 
HO-1 expression
9
T: 0.1, 1 and 10 mg/kg (i.v.); C: vehicle (saline). 
Single dose 30 minutes before injection of 
nociceptive stimulus
Male Wistar rats; 
age: N/A; weight: 
220 g, n=6 per 
group
Single injection of formalin 
(1.5%, 50 µL, 45 minutes) 
in TMJ. Injection of 
carrageenan (100 µg, 50 
µL, 1 hour) and 5-HT (75 
µg, 50 µL, 30 minutes) 
in the same TMJ. Single 
injection of 5-HT (225 
µg, 50 µL, 30 minutes) or 
capsaicin (2.5 µg, 20 µL, 




All doses reduced the 
nociceptive behavior in 
formalin test. The dose 
of 10 mg/kg reduced the 
nociceptive behavior induced 
for carrageenan, 5-HT and 
capsaicin
20




T: 0.01, 0.1, 1 mg/kg (i.v.); C: vehicle (saline) 
/ Single dose 30 minutes before zymosan 
injection
Male Wistar rats; 
weight: 160-220 
g; age: N/A; n=6 
per group
Single injection of 
zymosan (2 mg; 50 µL, 6 







All doses reduced 
mechanical hyperalgesia 
and MPO activity; only the 
dose of 1 mg/kg reduced 
inflammatory parameters in 
histopathological analysis 
and TNF-α and IL-1β, but 
increased HO-1 expression
16
T: 0.001, 0.01, 0.1 mg/kg (i.v.); C: vehicle 
(saline) / Single dose 30 minutes before formalin 
injection
Male Wistar rats; 
weight: 180-240 
g; age: N/A; n=5 
per group
Single injection of formalin 





All doses reduced the 







T: 1, 3, 9 mg/kg (s.c.); C: vehicle (saline); Single 
dose one hour before the injection of formalin 
Male Wistar rats; 
weight: 180-250 
g; age: N/A; n=5 
per group
Single injection of formalin 





All doses reduced 







T: 1, 3 and 9 mg/kg (s.c.) C:  vehicle (saline); 
Single dose one hour before injection of 
zymosan
Wistar rats; age: 
N/A; weight: 180-
240 g; n=6 per 
group
Single injection of 
zymosan (2 mg, 50 µL, 6 




All doses reduced 







T: 0.03, 0.3, 3 mg/kg (s.c.); C: vehicle (saline); 
Single dose 30 minutes before injection of 
nociceptive stimulus
Wistar rats; age: 
N/A; weight: 180-
240 g; n=5 per 
group
Single injection of formalin 
(1.5%, 50 µL, 45 minutes) 
or 5-HT (225 µ, 50 µL, 30 




All doses reduced 
nociceptive behavior induced 
by formalin; the doses of 
0.3 and 3 mg/kg reduced 





from beans of 
Theobroma cacao 
L. enriched with 
polyphenols
T: 424 μg/g or 638 µg/g of extract (in 25 µL; intra 
articular); C: sham / Single dose 24 h before the 




g; age: adult post-
estrous; n=N/A
Single injection of 
capsaicin (10 µmol/L, 




All doses reduced the 
expression of CGRP in 
trigeminal neurons
26
Figure 3- Characteristics of the studies included
Continued on the next page
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nociception. In the same experimental model, the 
treatment with a lectin from A. esculentus16 reduced 
TNF-α and IL-1β expression, whereas it increased HO-1 
expression. Interestingly, the treatment with the lectin 
from C. cupressoides9 reduced the expression of IL-1β 
and TNF-α, without altering the expression of HO-1.
In the model of CFA-induced TMJ inflammation, 
the polyphenol extract of grape seed (Vitis vinifera L.) 
reduced the expression of phosphorylated p38, glial 
fibrillary acidic protein (GFAP, a marker of activated 
astrocytes), and OX-42 (a marker of microglia 
activation) in trigeminal ganglia neurons when 
compared to animals injected with CFA.25 This model 
was also used by Magni, et al.18 (2018) that observed 
reduction in Iba-1 positive staining in trigeminal 
ganglia promoted by purple corn extract. 
Three studies used Theobrama cacao L. as 
intervention against TMD in rats. Pre-treatment with 
methanol extract of T. cacao beans enriched with 
polyphenols decreased CGRP expression in trigeminal 
neurons after capsaicin injection in TMJ.26 In another 
study, the inclusion of cocoa powder in the diet in 
TMD induced by capsaicin or CFA models reduced 
the mitogen-activated protein kinase (MAPK) and 
inducible nitric oxide synthase (iNOS) expression and 






T: 10% of total caloric diet; C: CFA/ Animals fed 





g; age: adult; n=4
Single injection of CFA 
(1:1 in saline, 50 µL, 7 














The treatment increased 
the basal expression 
of glutamate-aspartate 
transporter and MKP-1 and 
decreased the expression of 
CGRP. It also reduced the 
expression of P2X3, protein 
kinase A, P-p38, GFAP and 
OX-42 induced by CFA.
28
Polyphenol 
extract from grape 
seed of Vitis 
vinifera L.
T: 200 mg/kg/day on diet; C: naïve/ During 14 




g; age: adult; n= 
3 independent 
experiments
Single injection of CFA 
(1:1 in saline, 50 µL, 7 





All doses reduced 
the expression of 
phosphoriled-p38, GFAP, 







T: 1 and 10% of total caloric diet.; C: vehicle 
(dimethyl sulfoxide for acute and saline for 




g; age: adult; n= 
3 independent 
experiments
Single injection of 
capsaicin (10 µmol/L, 25 
µL, 2 hours) in eyebrow 
region for acute model. 
Single injection of CFA 
(1:1 saline, 50 µL, 5 days) 














increased basal MKP-1- and 
3 and CGRP expression. 
All doses reduced the 
expression of P-p38 and 
P-ERK in CFA or capsaicin 
models. All doses reduced 
the expression of inducible 
nitric oxide synthase in CFA 
model.
27
Continued from previous page
Figure 3- Characteristics of the studies included
Figure 4- Risk of bias of the selected studies
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and 3 expression in the trigeminal nerve.27 Besides, 
the inclusion of non-alkalized davao cocoa powder in 
the diet of CFA-injected rats bilaterally increased the 
expression of phosphorylated p38, GFAP, and OX-42 
in the spinal trigeminal nucleus.28 
Discussion
Although the classification of Research Diagnostic 
Criteria for TMD is divided into four groups 
(temporomandibular joint disorders, masticatory 
muscle disorders, headache and associated 
structures),29 in this review, natural products were only 
tested in models of TMJ disorders and in masticatory 
muscle disorders. However, these two groups are 
the most prevalent types of TMD.30 In most cases 
of TMJ disorder, inflammation occurs in the synovial 
membrane of TMJ. The analysis of TMJ of patients 
with this disorder revealed a massive production 
of cytokines, chemokines and other inflammatory 
mediators. This inflammatory process is responsible for 
the pain and other signs and symptoms associated with 
disorders.31,32 In agreement with these findings, most 
studies identified in this review used phlogistic agents 
to induce inflammation in the synovial membrane, but 
different purposes can be identified since many studies 
only evaluated nociception, although others assessed 
the inflammatory process by using protocols involving 
zymosan or CFA lasting from induction for measuring 
neuronal or glial markers. Finally, NGF injection caused 
mechanical nociception in 3 days.
Different types of NP were found for the treatment 
of TMD, such as lectins, extracts of plants or algae, 
sulfated polysaccharides, powder preparations or 
isolated compounds that presented protective effects 
in models of experimental TMD. 
Lectins bind to sugars present in the cell membrane, 
causing biological changes. This property may support 
the treatment of inflammatory and painful diseases.33 
Three different lectins (frutalin, a lectin from A. 
esculentus seeds and another from green seaweed 
of C. cupressoides) were described regarding their 
ability to reduce nociception and inflammation in TMJ. 
The antinociceptive activity of frutalin depends of a 
nitrergic mechanism and it also modulates TRPA1 and 
TRPM8 channels.10 On the other hand, interestingly, 
the lectin from A. esculentus increased HO-1 and 
reduced TNF-α and IL-1β expression.16 In fact, HO-1 
expression was associated with anti-inflammatory 
actions.34 Alves, et al.21 (2018) also showed that the 
treatment with this lectin reduces TNF-α concentration 
and it is opioid-dependent. For the treatment with C. 
cupressoides lectin no alteration of HO-1 expression 
was detected in TMJ, in spite of the results of a 
previous study showing that this lectin inhibited the 
immunoreactivity of HO-1, cytokines (IL-1β, IL-6 and 
TNF-α) and cyclooxygenase-2 in rat paws injected 
with carrageenan.35 A HO-1 expression-dependent 
mechanism was also observed based on the treatment 
with T. toxicaria extract after the injection of zymosan 
in TMJ.15 
Polysaccharide sulfated from seaweed also 
presented beneficial effects in TMD models. The 
treatment with the sulfated polysaccharide fraction 
from C. cupressoides caused antinociception followed 
by reduced leukocyte infiltration in zymosan-injected 
TMJ,17 whereas the polysulfated fraction of G. cornea 
in the formalin model was described as dependent 
on opioid receptors and nitric oxide pathways as 
well as HO-1 activation and formation of IL-10 in the 
trigeminal ganglion and subnucleus caudalis,11 which 
corroborated previous results about this fraction down-
regulated the production of proinflammatory mediators 
associated with the involvement of the HO-1 pathway36 
The antinociceptive action of sulfated polysaccharides 
from S. filiformis also involved opioid receptors with 
increased release of β-endorphin in the subnucleus 
caudalis, while in TMJ the plasma protein extravasation 
and TNF-α and IL-1β concentrations were lower.19
Cocoa preparations were investigated in three 
studies. In the model of capsaicin-induced nociception, 
the treatment with methanol extract of cocoa beans 
reduced CGRP expression in the trigeminal ganglion.26 
The CGRP is a sensorial vasoactive neuropeptide 
released in response to sensory fiber stimulation and 
it is involved in peripheral and central sensitization 
in TMD.37 The study by Cady and Durham27 (2010) 
also showed that the activation of p38 and ERK in the 
trigeminal ganglion neurons after CFA or capsaicin 
injection in TMJ was reduced by the treatment with 
cocoa powder incorporated in the diet of rats, and 
that iNOS expression was reduced in the CFA model. 
Finally, it was demonstrated that cocoa powder 
reduced the activation of PKA and p38 in neuron and 
glia along with the expression of GFAP and OX-42 in the 
spinal trigeminal nucleus,28 indicating that the cocoa 
treatment affects the activation of both neurons and 
OLIVEIRA JP, NAMPO FK, SOUZA MT, CERCATO LM, CAMARGO EA
J Appl Oral Sci. 2020;28:e202002728/10
glia. In fact, glial cells have relevant participation in 
nociceptive response modulation in trigeminal ganglia 
and nuclei and contribute to neuronal excitability and 
chronic inflammation.32 These results suggest that 
regular cocoa intake is beneficial in the treatment of 
TMD.
Furthermore, the treatment with ethanol extract 
from purple corn also affected microglia, as detected by 
reduced Iba-1 expression and shift of cell polarization 
to an anti-inflammatory phenotype after 1 to 3 days 
of CFA injection in TMJ.18 Attenuation of microglial 
activation in spinal trigeminal nuclei was also found 
for the treatment with polyphenol extract from grape 
seeds (Vitis vinifera) after 7 days of CFA injection in 
TMJ.25 Grape seed extract has been proposed as a 
promising anti-inflammatory agent, particularly due 
to its anthocyanidin content,38,39 considered as a class 
of compounds that can reduce neuroinflammation.40 
Interestingly, few isolated compounds were tested 
in TMD models since only (-)-α-bisabol, eucalyptol, 
and three cannabinoids were tested in models of 
formalin-induced nociception in TMJ. The mechanisms 
underlying these effects must be better elucidated. 
Eucalyptol is described as an agonist of TRPM8 
leading to anti-inflammatory effects,41 a finding that 
corroborates its effects in a TMD models. On the 
other hand, (-)-α-bisabol effects were suggested 
to be partly dependent on TRPA1,22 although this 
remains unconfirmed. Cannabidiol and cannabinol 
are cannabis-derived compounds largely known to 
produce their effects by modulating the cannabinoid 
receptors pathway.24,42
Strengths and limitations
The strength of this systematic review is related to 
the theme, since no review has evaluated the efficacy 
of NP in animal models of TMD. It also collected 
information in many databases, without restriction on 
language or publication. The lack of methodological 
rigor and detailed information is one limitation of 
the studies included. However, these methodological 
deficiencies are common in pre-clinical studies.43 Other 
relevant issue is related with the injection of phlogistic 
agents to TMJ partially mimics the alterations found in 
clinic conditions, but can provide important information 
for translational research. The lack of investigation 
about possible adverse events caused to NP in TMD 
models in most studies included is also a limitation. 
These issues can influence success in investigation of 
new treatment approaches. 
Future research and conclusions
A considerable number of natural products have 
already been tested against innocuous treatment in 
animal models of TMD. All of them presented positive 
results in the evaluated outcomes, mostly by reducing 
nociception, inflammation or glial activation. However, 
the lack of methodological clarity may impair the 
validity of the results. Therefore, future studies in 
this field should consider some details of experimental 
design, such as:
- Randomization of animals in the cages and in 
experimental procedures, as well as performance and 
analysis of experiments with blind researchers;
-Reporting more details about procedures 
performed to enable reproducibility of the research;
-Reporting possible adverse effects of natural 
products used for the treatment of TMD, to encourage 
the use of natural products in more studies.
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